Arminder Deol

Arminder had worked as an operational researcher for four years on a Children's Investment Fund Foundation (CIFF) funded project, with a focus on developing tools and providing evidence to help reach the WHO aims of the control and elimination of STH infection and schistosomiasis.  She worked together with the WHO and modelling groups as well as the Ministries of Health of endemic countries to develop tools and strategies for control programmes and provide evidence through a three year data collection exercise in Uganda involving over 7000 individuals across all age groups, as well as through analyses of the SCI Foundation’s extensive historical datasets. The evidence gathered will help assist the WHO in the refinement of the guidelines on the way forward to reach the ambitious WHO targets of controlling and eliminating these debilitating diseases.  She recently expanded her disease research portfolio to include another chronic infectious disease, tuberculosis and is currently an Assistant Professor at the Centre for the Mathematical Modelling of Infectious Diseases (CMMID) at the London School of Hygiene and Tropical Medicine with the Tuberculosis Modelling Group led by Professor Richard White.

Arminder holds a PhD in Epidemiology from Imperial College London. In addition, she completed her MSc in 2012 in Epidemiology (mathematical modelling) at Imperial College London and subsequently went on to work in population genetics of schistosomiasis at the Dept. of Infectious Disease Epidemiology with Professor Joanne Webster.  She has worked with the Partnership for Child Development providing statistical support, as well as the SCI Foundation with operational research. She was also involved with the data collection from Mozambique, where she spent several weeks in the field, assisting the teams and identifying infection intensities through microscopy as part of the Schistosomiasis Consortium for Operational Research and Evaluation (SCORE) project. Arminder has also worked for a private organisaton where she was involved in the development of an economic Markov STI model (gonorrhoea, chlamydia and coinfection) and has spent several weeks in China where she collected and analysed samples from the field for Paragonimus westermani using various laboratory techniques at Imperial College London. Prior to her career in public health and epidemiology, Arminder worked in the private sector (pharma and stem cell research) as a UK/EU manager.